Flupenthixol Decanoate in Methamphetamine Smoking – 1

Overview

The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.

Full Title of Study: “Flupenthixol Decanoate in Methamphetamine Smoking”

Study Type

  • Study Type: Interventional
  • Study Design
    • Primary Purpose: Treatment

Interventions

  • Drug: Flupenthixol

Clinical Trial Outcome Measures

Primary Measures

  • Methamphetamine use

Participating in This Clinical Trial

Please contact site for information.

Gender Eligibility: All

Minimum Age: 22 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • National Institute on Drug Abuse (NIDA)
  • Collaborator
    • Friends Research Institute, Inc.
  • Overall Official(s)
    • Frank Gawin, M.D., Principal Investigator, Friends Research Institute, Inc.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.